SII Resumes Covishield Manufacturing As Covid Cases On Rise
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine ...
New Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine ...
Bhubaneswar: In view of resurgence of Covid-19 cases due to Omicron sub-variants, Odisha Government will recommence the vaccination drive from ...
Pune: The Serum Institute of India (SII) has sought the drug regulator's approval for market authorisation of its COVID-19 vaccine ...
Hyderabad: The Serum Institute of India (SII) on Friday said that the price of a booster dose of Covishield will ...
Hyderabad: The National Technical Advisory Group on Immunisation (NTAGI) on Sunday said that the second dose of the Covid-19 vaccine ...
New Delhi: The Drugs Controller General of India (DCGI) on Thursday granted regular market approval to Serum Institute of India's ...
Ranchi: A 55-year-old man in Jharkhand, who was bedridden for the last five years after a massive accident, started to ...
New Delhi: A mix of Covishield and Covaxin, the two main vaccines of India's Covid vaccination programme, can actually yield ...
New Delhi: Several government-run vaccination centres in Delhi will be shut on Tuesday because the city has exhausted its Covishield ...
New Delhi: Following pressure from India, several European countries including, Austria, Germany, Slovenia, Greece, Iceland, Ireland and Spain, and Switzerland ...